Human Papillomavirus Vaccination and Human Papillomavirus-Associated Cancer Rates Within Florida Counties

被引:7
|
作者
Staras, Stephanie A. S. [1 ,2 ]
Huo, Tianyao [1 ]
Rothbard, Sarah M. [1 ]
Hall, Jaclyn M. [1 ,2 ]
Cho, Hee D. [1 ]
Guo, Yi [1 ]
Richardson, Eric [1 ]
Salloum, Ramzi G. [1 ,2 ]
Thompson, Lindsay A. [1 ,2 ,3 ]
Silver, Natalie L. [4 ]
Shenkman, Elizabeth A. [1 ,2 ]
机构
[1] Univ Florida, Coll Med, UF Dept Hlth Outcomes & Biomed Informat, 2004 Mowry Rd,Room 2238, Gainesville, FL 32610 USA
[2] Univ Florida, UF Inst Child Hlth Policy, Gainesville, FL USA
[3] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL USA
[4] Univ Florida, Coll Med, UF Dept Otolaryngol, Gainesville, FL USA
关键词
AGED; 13-17; YEARS; UNITED-STATES; ADVISORY-COMMITTEE; COVERAGE; TRENDS; RECOMMENDATIONS; MULTILEVEL; MORTALITY; BURDEN; RISK;
D O I
10.1016/j.amepre.2021.05.016
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: To direct interventions, the Florida counties with the greatest risk of current and future human papillomavirus-associated cancers were identified by estimating county level (1) percentages of adolescents aged 13-17 years who initiated (>= 1 dose) and were up to date (2-3 doses) for the human papillomavirus vaccine and (2) human papillomavirus-associ-ated cancer incidence rates. Methods: Records were obtained for human papillomavirus vaccinations from the Florida immunization registry (2006-2019), incident cancer cases from the Florida registry (2013-2017), and annual population counts from the Florida Department of Health (2006-2019). In 2020, annual county-level human papillomavirus vaccine initiation, human papillomavirus vaccine up-to-date, and age-adjusted human papillomavirus-associated cancer incidence rates were estimated. Results: Among adolescents aged 13-17 years, average 2018-2019 county-specific human papillomavirus vaccine initiation ranged from 38% to 100% for females and from 34% to 96% for males. Up-to-date estimates ranged from 20% to 72% for females and from 24% to 77% for males. The majority (78%) of counties with initiation and up-to-date estimates within the lowest tercile were located in Northern Florida. County-specific 2013-2017 annualized, adjusted human papillomavirus-associated cancer incidence rates ranged from 0 to 29.8 per 100,000 among females and from 5.4 to 24.1 per 100,000 among males. Counties within the highest tercile for human papillomavirus-associated cancers were primarily (90% for females and 77% for males) located in Northern Florida. Conclusions: Human papillomavirus-associated cancer risk varies widely across Florida counties, with particularly high risk within Northern Florida. Targeting interventions toward counties with low vaccination and high cancer rates may reduce human papillomavirus-associated cancers. (C) 2021 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:812 / 820
页数:9
相关论文
共 50 条
  • [1] Human Papillomavirus-Associated Oropharyngeal Cancer
    Dahlstrom, Kristina R.
    Anderson, Karen. S.
    Sturgis, Erich M.
    JAMA ONCOLOGY, 2017, 3 (02) : 161 - 162
  • [2] Human Papillomavirus Vaccination and Human Papillomavirus-Related Cancer Rates
    Adekanmbi, Victor
    Sokale, Itunu
    Guo, Fangjian
    Ngo, Jessica
    Hoang, Thao N.
    Hsu, Christine D.
    Oluyomi, Abiodun
    Berenson, Abbey B.
    JAMA NETWORK OPEN, 2024, 7 (09)
  • [3] Human Papillomavirus-Directed Therapeutics for Human Papillomavirus-Associated Oropharyngeal Cancer
    Campbell, Jean S.
    Pai, Sara, I
    CANCER JOURNAL, 2022, 28 (05): : 407 - 415
  • [4] Human Papillomavirus-Associated Head and Neck Cancer
    Nogues, Juan C.
    Fassas, Scott
    Mulcahy, Collin
    Zapanta, Philip E.
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2021, 34 (04) : 832 - 837
  • [5] Human Papillomavirus-Associated Cancers
    Alhamlan, Fatimah S.
    Alfageeh, Mohamed B.
    Al Mushait, Mona A.
    Al-Badawi, Ismail A.
    Al-Ahdal, Mohammed N.
    MICROBIAL PATHOGENESIS: INFECTION AND IMMUNITY, 2ND EDITION, 2021, 1313 : 1 - 14
  • [6] Human papillomavirus-associated diseases
    Grce, Magdalena
    Mravak-Stipetic, Marinka
    CLINICS IN DERMATOLOGY, 2014, 32 (02) : 253 - 258
  • [7] Human Papillomavirus Vaccination Expected to Reduce Human Papillomavirus-Associated Cancers and May Lessen Racial/Ethnic Disparities of Cancer Incidence
    Cates, Joan R.
    JOURNAL OF ADOLESCENT HEALTH, 2019, 65 (06) : 709 - 710
  • [8] Therapeutic vaccination for the treatment of mucosotropic human papillomavirus-associated disease
    Chu, NR
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2003, 3 (03) : 477 - 486
  • [9] Rural-Urban Differences in Human Papillomavirus-associated Cancer Trends and Rates
    Zahnd, Whitney E.
    Rodriguez, Christofer
    Jenkins, Wiley D.
    JOURNAL OF RURAL HEALTH, 2019, 35 (02): : 208 - 215
  • [10] Treatment Deintensification for Human Papillomavirus-Associated Oropharyngeal Cancer
    Arnaoutakis, Demetri
    Sumer, Baran D.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (12) : 3463 - 3465